The effects of renin–angiotensin system inhibitors on mortality, cardiovascular events, and renal events in hypertensive patients with diabetes: a systematic review and meta-analysis of randomized controlled trials

2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults

(2018) Paul K. Whelton et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Japanese Clinical Practice Guideline for Diabetes 2016

(2018) Masakazu Haneda et al.   Journal of Diabetes Investigation

2018 ESC/ESH Guidelines for the management of arterial hypertension

(2018) Bryan Williams et al.   EUROPEAN HEART JOURNAL

Blood Pressure Lowering in Type 2 Diabetes

(2015) Connor A. Emdin et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Comparative efficacy and safety of blood pressure-lowering agents in adults with diabetes and kidney disease: a network meta-analysis

(2015) Suetonia C Palmer et al.   LANCET

Effects of Valsartan Versus Amlodipine in Diabetic Hypertensive Patients With or Without Previous Cardiovascular Disease

(2013) Kentaro Yamashita et al.   AMERICAN JOURNAL OF CARDIOLOGY

2013 ESH/ESC Guidelines for the management of arterial hypertension

(2013)   EUROPEAN HEART JOURNAL

β-Blockers in Patients With Intermittent Claudication and Arterial Hypertension

(2011) Christine Espinola-Klein et al.   HYPERTENSION

Role of diabetes and obesity in outcomes of the candesartan antihypertensive survival evaluation in Japan (CASE-J) trial

(2010) Kazuwa Nakao et al.   HYPERTENSION RESEARCH

Masked nocturnal hypertension—a novel marker of risk in type 2 diabetes

(2009) M. Wijkman et al.   DIABETOLOGIA

Effects of Candesartan Compared With Amlodipine in Hypertensive Patients With High Cardiovascular Risks

(2008) Toshio Ogihara et al.   HYPERTENSION

Patient-Important Outcomes in Registered Diabetes Trials

(2008) Gunjan Y. Gandhi   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION